IN2013MU01159A - - Google Patents

Info

Publication number
IN2013MU01159A
IN2013MU01159A IN1159MU2013A IN2013MU01159A IN 2013MU01159 A IN2013MU01159 A IN 2013MU01159A IN 1159MU2013 A IN1159MU2013 A IN 1159MU2013A IN 2013MU01159 A IN2013MU01159 A IN 2013MU01159A
Authority
IN
India
Prior art keywords
metformin
salts
compositions
sitagliptin
present
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Venkataramana Naidu
Atul Patil
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/060029 priority Critical patent/WO2014167437A1/en
Priority to IN1159MU2013 priority patent/IN2013MU01159A/en
Priority to EP14721970.3A priority patent/EP3033075A1/en
Priority to US14/766,753 priority patent/US20150374688A1/en
Publication of IN2013MU01159A publication Critical patent/IN2013MU01159A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1159MU2013 2013-03-26 2014-03-21 IN2013MU01159A (enrdf_load_stackoverflow)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/IB2014/060029 WO2014167437A1 (en) 2013-03-26 2014-03-21 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
IN1159MU2013 IN2013MU01159A (enrdf_load_stackoverflow) 2013-03-26 2014-03-21
EP14721970.3A EP3033075A1 (en) 2013-03-26 2014-03-21 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
US14/766,753 US20150374688A1 (en) 2013-03-26 2014-03-21 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1159MU2013 IN2013MU01159A (enrdf_load_stackoverflow) 2013-03-26 2014-03-21

Publications (1)

Publication Number Publication Date
IN2013MU01159A true IN2013MU01159A (enrdf_load_stackoverflow) 2015-04-24

Family

ID=54395446

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1159MU2013 IN2013MU01159A (enrdf_load_stackoverflow) 2013-03-26 2014-03-21

Country Status (1)

Country Link
IN (1) IN2013MU01159A (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
DOP2017000109A (es) Derivados de feniltriazol sustituido con hidroxialquilo y sus usos
PH12015500780A1 (en) Rsv antiviral compounds
TN2015000278A1 (en) Autotaxin inhibitors
IL231591A0 (en) Converted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
SG11201601363YA (en) Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid
PH12016501807A1 (en) Novel compounds
PH12014501991B1 (en) Phenicol antibacterials
CL2014000849A1 (es) Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas.
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
MX2015011359A (es) Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2).
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
CL2014002845A1 (es) Compuestos derivados de pirazol inhibidores de sglt1; metodo para tratar la diabetes; composicion farmaceutica; uso del compuesto para el tratamiento de la diabetes tipo 1 y tipo 2.
PH12015502747A1 (en) Novel compounds for the treatment of cancer
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
MX2015014958A (es) Nuevos derivados de triazolona o sales de la misma y composicion farmaceutica que comprende a la misma.
WO2016020408A3 (en) Compounds for preventing ototoxicity
IN2013MU01158A (enrdf_load_stackoverflow)
IN2013MU01159A (enrdf_load_stackoverflow)
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
NZ717880A (en) Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors
IN2013MU01224A (enrdf_load_stackoverflow)
IN2013MU01225A (enrdf_load_stackoverflow)
IN2013MU01223A (enrdf_load_stackoverflow)